The growing incidence of scarlet fever is anticipated to increase market growth. Around 10% of the population contracts group streptococcal pharyngitis. Among this group, almost 10% develop scarlet fever. The increase in the number of scarlet fever medications being delivered through retail pharmacies and the rise in the number of retail pharmacies in highly evolved countries create huge opportunities for market growth.
Data Bridge Market Research shows Global Scarlet Fever tends to have a healthy CAGR from 2022 to 2029.
" Increasing Treatment Methods Surge the Market Growth"
The numerous treatment options are helping in fast patient recovery. Antibiotics are the most usual treatment option preferred for scarlet fever treatment. Also, penicillin or amoxicillin is the ultimate antibiotic for scarlet fever treatment. However, few patients showed allergic reactions to penicillin, and narrow-spectrum cephalosporins (cephalexin, cefadroxil), azithromycin, clarithromycin, and clindamycin were recommended, among others. This creates more such opportunities for the market. Thus, this factor boosts market growth.
What restraints the growth of the Global Scarlet Fever Market?
" High Cost of Scarlet fever Treatment Processes"
The increasingly high costs associated with R&D activities, the cost related to new drug development, the threat of failure, and varied adverse effects will evolve as one of the primary limitations for the market. The increasing expenditure associated with antibiotics and other substitutes impedes the market growth. Antibiotics such as amoxicillin or penicillin are costing high and impeding the market's growth. All these major factors impede the growth of the market.
Segmentation: Global Scarlet Fever Market
The global scarlet fever market is segmented on the basis of treatment, route of administration, distribution channel and end-user.
- Based on treatment, the global scarlet fever market is segmented into antibiotics and others.
- Based on treatment type, the global scarlet fever market is segmented into medication, plasma exchange therapy, immunoglobulin therapy.
- Based on route of administration, global scarlet fever market is segmented into oral, parenteral, others.
- Based on end-users, the global scarlet fever market is segmented into hospitals, homecare, specialty clinics, others.
- Based on distribution channel, the global scarlet fever market has been bifurcated into hospital pharmacy, retail pharmacy, online pharmacy, others.
Regional Insights: North America is expected to dominate the Global Scarlet Fever Market
North America dominates the market due to the growing incidence of scarlet fever and increasing research and development activities. Additionally, increasing healthcare expenditure and the availability of treatment options will further boost the market's growth rate in this region.
Asia-Pacific is expected to grow in the forecast period of 2022-2029 due to growing government initiatives for infection control and the wide adoption of several new technologies for infection control. Also, the increasing research activities associated with scarlet fever enhance the market growth.
To know more about the study, visit, https://www.databridgemarketresearch.com/reports/global-scarlet-fever-market
The Prominent Key Players Operating in the Global Scarlet Fever Market Include:
- AstraZeneca (U.K.)
- Lilly (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Sanofi (France)
- Novartis AG (Switzerland)
- Sun Pharmaceutical Industries Ltd. (India)
- Aurobindo Pharma (India)
- Lupin (India)
- Merck & Co., Inc. (U.S.)
- Pfizer Inc. (U.S.)
- GSK plc (U.K.)
- Hikma Pharmaceuticals PLC (U.K.)
- Cipla Inc. (India)
- Melinta Therapeutics LLC (U.S.)
- KYORIN Pharmaceutical Co., Ltd (Japan)
- NIKSAN PHARMACEUTICAL (India)
- Maya Biotech Private Limited (India)
Above are the key players covered in the report, to know about more and exhaustive list of global scarlet fever market companies contact, https://www.databridgemarketresearch.com/contact
Research Methodology: Global Scarlet Fever Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
